Devices › Needle, hypodermic, single lumen
Device brand name · Hypodermic single lumen needle
BD Vacutainer Eclipse Blood Collection Needle: medical device reports filed with FDA
2,116 reports name it, 2017–2026. Manufacturer given most often on reports: Becton Dickinson & Bd. Product code FMI.
- 2,116
- device reports naming the brand
- 0% of all MAUDE reports · about 244 a year
- 627
- reports, 12 months to August 2026
- 235 in the 12 months before
- 91%
- classified as malfunction
- 87.6% across the product code
- 0%
- classified as death, as reported
- 0 reports · not verified by FDA
2,116 medical device reports received by FDA name the brand "BD Vacutainer Eclipse Blood Collection Needle" (hypodermic single lumen needle); the manufacturer given most often on reports is Becton Dickinson & Bd; received from November 2017 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
627 reports arrived in the 12 months to August 2026, up 167% from 235 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (91%) and injury (9%); across all needle, hypodermic, single lumen reports (product code FMI) death is recorded in 0.2% and malfunction in 87.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are difficult or delayed activation (25.5%), leak/splash (18.3%) and fluid/blood leak (13.4%). The patient problems coded most often are needle stick/puncture, no patient involvement and exposure to body fluids. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 39,876 reports carrying product code FMI. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Difficult or delayed activation | 539 | 25.5% | 2.1% |
| Leak/splashthe device leaked | 387 | 18.3% | 8.5% |
| Fluid/blood leak | 283 | 13.4% | 3.3% |
| Product quality problem | 243 | 11.5% | 1.4% |
| Device contamination with chemical or other material | 131 | 6.2% | 5.4% |
| Breakthe device broke | 112 | 5.3% | 12.7% |
| Detachment of device or device componentpart of the device came off | 92 | 4.3% | 2.7% |
| Separation problem | 82 | 3.9% | 0.6% |
| Loss of or failure to bond | 45 | 2.1% | 0.1% |
| Device markings/labelling problema problem with the device markings or label | 44 | 2.1% | 2.2% |
| Physical resistance/sticking | 43 | 2% | 0.5% |
| Premature separation | 23 | 1.1% | 0.1% |
| Detachment of device component | 15 | 0.7% | 3% |
| Difficult to insertthe device was hard to insert | 14 | 0.7% | 0.4% |
| Volume accuracy problem | 13 | 0.6% | 0.3% |
| Material protrusion/extrusion | 12 | 0.6% | 1.3% |
| Packaging problem | 12 | 0.6% | 1.2% |
| Difficult or delayed positioning | 10 | 0.5% | 0.1% |
| Material separation | 9 | 0.4% | 1.2% |
| Retraction problem | 9 | 0.4% | 0.6% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Needle stick/puncture | 169 | 8% |
| No patient involvement | 63 | 3% |
| Exposure to body fluids | 33 | 1.6% |
| Nerve damage | 10 | 0.5% |
| Painpain, site not specified | 10 | 0.5% |
| Blood loss | 5 | 0.2% |
| Laceration(s) | 3 | 0.1% |
| Discomfortdiscomfort | 2 | 0.1% |
| Injurya physical injury | 2 | 0.1% |
| Altered state of consciousness | 1 | 0% |
| Bruise/contusion | 1 | 0% |
| Extravasation | 1 | 0% |
| Foreign body in patientpart of a device left in the patient | 1 | 0% |
| Hemorrhage/blood loss/bleeding | 1 | 0% |
| Hepatitis | 1 | 0% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | BD Vacutainer Eclipse Blood Collection Needle | Product code FMI | All MAUDE reports |
|---|---|---|---|
| Reports | 2,116 | 39,876 | 26,136,888 |
| Share of that pool | — | 5.3% | 0% |
| Classified as death, per 1,000 reports | 0 | 2 | 9 |
| Classified as injury | 9% | 10.5% | 36.2% |
| Classified as malfunction | 91% | 87.6% | 62.3% |
| Filed by the manufacturer | 98.7% | 92.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code FMI
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Unspecified Bd Pen Needle | 1,820 | 0 | 0.1% |
| Bd Safetyglide Needle | 1,258 | 3 | 0% |
| Bd Precisionglide Needle | 1,229 | 0 | 0% |
| Bd Nano 2nd Gen Pen Needle | 788 | 0 | 0% |
| Bd Ultra Fine Pen Needles | 656 | 0 | 0% |
| Pen Ndl 32g 4mm Pro 100 Box 1200 Us | 510 | 9 | 0% |
| BD SafetyGlide | 576 | 127 | 0% |
| Ez-Io Power Driver | 463 | 0 | 2.2% |
| BD Vacutainer Eclipse Blood Collection Needle with Pre-Attached Holder | 423 | 18 | 0% |
| Bd Ultra Fine Pen Needle | 375 | 0 | 0% |
| Bd Safetyglide Needle Only 25 G | 328 | 0 | 0% |
| Unspecified Bd Needle | 327 | 0 | 0% |
| Bd Ultra-Fine Pen Needle | 320 | 0 | 0% |
| Magellan | 330 | 20 | 0% |
| Bd Vacutainer Flashback Blood Collection Needle | 519 | 0 | 0% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about BD Vacutainer Eclipse Blood Collection Needle reports
How many FDA reports name BD Vacutainer Eclipse Blood Collection Needle?
2,116 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 627 in the latest 12 months.
What kinds of events are reported?
malfunction (91%) and injury (9%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
difficult or delayed activation (25.5%), leak/splash (18.3%), fluid/blood leak (13.4%), product quality problem (11.5%) and device contamination with chemical or other material (6.2%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (98.7%) and voluntary reports (0.7%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that BD Vacutainer Eclipse Blood Collection Needle was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.